UC enters Reuters’ top 100 most innovative universities
List includes University of Cincinnati among world’s biggest contributors to scientific advancement, technology development
Reuters now counts the University of Cincinnati among the 100 most innovative institutions of higher learning in the world.
UC entered Reuters’ 2018 rankings at No. 80, its first appearance since the news organization began the list in 2015. According to Reuters, "the list identifies and ranks the educational institutions doing the most to advance science, invent new technologies and power new markets and industries.”
UC is one of 46 American institutions named on the list, and is ranked ahead of the State University of New York System, the University of Virginia, the University of Iowa, the University of Miami and Arizona State University.
The debut of UC on Reuters’ top 100 most innovative universities coincides with the launch of the university’s bicentennial celebration and comes in the same year as the launch of Next Lives Here, the university’s strategic direction. Announced in February by UC President Neville Pinto, Next Lives Here names innovation as one of three key platforms necessary to advance the university’s vision of “leading public universities into a new era of innovation and impact.”
Reuters’ inclusion of UC on its list of top innovation universities comes within a week of the university’s celebration of the grand opening of the 1819 Innovation Hub, UC’s state-of-the-art destination for thinking, making, doing, discovery and delivery.
Innovate with industry
The University of Cincinnati is the birthplace of cooperative education. UC's 1819 Innovation Hub takes experiential learning to a new level by providing students a place where they can interact and innovate with Cincinnati's vibrant business community. Learn how you can become part of the university's 1819 Innovation Hub.
Become a Bearcat
Apply to an undergraduate program at UC, or a graduate program, and become a part of UC's innovative vision for the future.
Related Stories
Miniature marvels: A librarian’s lifelong passion finds a home at UC
March 9, 2026
In the mid-1950s Melinda C. Wells Brown moved to Cincinnati to live with her great aunt and became captivated by a collection of miniature Shakespeare plays her great aunt kept on display. Brown came to Cincinnati after the death of her father, and without her great aunt’s guidance and generosity, she would not have been able to continue her education. Her great aunt’s holistic support was instrumental during Brown’s undergraduate studies at the University of Cincinnati — where she worked in the University Library (now known as Blegen Library) and uncovered a deep passion for literature and libraries.
Phase 1 trial tests probiotic treatment for radiation side effects in the gut
March 9, 2026
The University of Cincinnati Cancer Center’s Bailey Nelson, MD, has been awarded a $50,000 pilot grant from the Cancer Center to open a Phase 1 trial testing if a probiotic supplement can reduce gastrointestinal symptoms for patients undergoing whole pelvis radiotherapy.
Is uACR the key to cardiovascular and kidney disease prevention?
March 8, 2026
As a precision biomarker, the urinary albumin-to-creatinine ratio (uACR) can guide physicians toward personalized, patient-centered prevention and treatment of both cardiovascular disease (CVD) and chronic kidney disease (CKD), according to new data published in the Journal of Internal Medicine.
Driven by her own pain
March 8, 2026
Endometriosis is a painful and often debilitating disease that affects an estimated 6.5 million women in the U.S. It occurs when tissue similar to the lining of the uterus grows outside of it, causing pain, inflammation and sometimes infertility. Now a University of Cincinnati College of Medicine researcher is developing what is believed to be the first at-home diagnostic test.
Can you grow new brain cells?
March 6, 2026
As National Geographic recently reported, a pair of new studies have provided fresh evidence in the long-running scientific debate on if adults can grow new brain cells. The result could be game-changing for treating diseases such as Alzheimer’s and dementia.
Using GLP-1s for weight loss, maintenance after bariatric surgery
March 5, 2026
Bariatric surgery has become a cornerstone treatment for severe obesity and its related comorbidities, offering superior long-term efficacy compared with lifestyle and pharmacologic interventions alone. Yet persistent clinical gaps remain in a subset of patients, including insufficient weight loss and postoperative weight regain.